Europe Anesthesia Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Europe General Anesthesia Drugs Market and it is segmented by Drug Type (General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, and Other General Anesthesia Drugs) and Local Anesthesia Drugs (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, and Other Local Anesthesia Drugs), Route of Administration (Inhalation, Injection, and Other Routes of Administration), Application (General Surgeries, Plastic and Cosmetic Surgeries, Dental Surgeries, and Other Applications), and Geography (United Kingdom, Germany, France, Italy, Spain, and Rest of Europe). The market provides the value (in USD million) for the above-mentioned segments.

Europe Anesthesia Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Anesthesia Drugs Industry Overview

The Europe anesthesia drugs market is highly competitive and consists of a few major players. In terms of market share, a few of the major players currently dominate the market. Companies like AbbVie Inc., B. Braun Melsungen AG, Baxter, Fresenius SE & Co. KGaA, and Pfizer Inc., among others, hold substantial shares in the market.

Europe Anesthesia Drugs Market Leaders

  1. Aspen Pharmacare Holdings Limited

  2. Piramal Group

  3. Baxter International

  4. AbbVie Inc.

  5. Viatris Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Picture3.png

Europe Anesthesia Drugs Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?